Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF

✍ Scribed by Chaudhary, Lubna; Awan, Farrukh; Cumpston, Aaron; Leadmon, Sonia; Watkins, Kathy; Tse, William; Craig, Michael; Hamadani, Mehdi

• Book ID: 120709748
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 93 KB
• Category: Article
• ISSN: 0733-2459
• DOI: 10.1002/jca.21280